Back to search
Dementia-related Psychosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia-related Psychosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia-related Psychosis trials you may qualify forForensic patients often display cognitive deficits, particularly in the domain of executive functions, that represent a challenge to forensic rehabilitation. O…
This observational study aims to provide new insights into the nature and classification of severe mental illness and dementias that in time should help improve…
The validation of biomarkers allowing the discrimination of cognitive and behavioral disorders of psychiatric origin from those of neurodegenerative origin woul…
To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical researc…
This open-label study will utilize treatment with BXCL501 in order to assess the suitability of patient-and lay informant-assessed outcome measures for evaluati…
This is a single-arm pilot study to examine the impact of BXCL501 (sublingual film formulation of dexmedetomidine) administration on reducing the severity of un…
This is an in-clinic, single arm, open-label study assessing tachyphylaxis, tolerance, and withdrawal following repeated doses of Igalmi in adult males and fema…